Does reduced cathepsin activity contribute to skin and lung fibrosis in patients with systemic sclerosis and related disorders?
Rheumatology (Oxford)
.
2024 Mar 1;63(3):e81-e82.
doi: 10.1093/rheumatology/kead549.
Authors
Mark Garton
1
,
Clive Kelly
2
Affiliations
1
Department of Medicine, Royal Shrewsbury Hospital, Shrewsbury, UK.
2
Departments of Rheumatology and Chest Medicine, James Cook University Hospital, Middlesbrough, UK.
PMID:
37831911
DOI:
10.1093/rheumatology/kead549
No abstract available
MeSH terms
Humans
Pulmonary Fibrosis* / etiology
Scleroderma, Systemic* / complications
Skin